Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lidia Elizabeth de la Cruz-Álvarez"'
Autor:
Héctor Isaac Rocha-González, Lidia Elizabeth De la Cruz-Álvarez, Ashuin Kammar-García, Samuel Canizales-Quinteros, Juan Carlos Huerta-Cruz, Lina Marcela Barranco-Garduño, Juan Gerardo Reyes-García
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 1354, p 1354 (2021)
Journal of Personalized Medicine; Volume 11; Issue 12; Pages: 1354
Journal of Personalized Medicine
Journal of Personalized Medicine; Volume 11; Issue 12; Pages: 1354
Journal of Personalized Medicine
The efficacy of anti-obesity drugs usually does not consider the high degree of interindividual variability in responses to the drug which could affect the decision to withdraw the drug early due to ineffectiveness or to continue therapy according to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa047213d7e395282ed0f6b13def80b7
https://www.mdpi.com/2075-4426/11/12/1354
https://www.mdpi.com/2075-4426/11/12/1354
Autor:
Juan Carlos Huerta-Cruz, Francisco J. Flores-Murrieta, Lidia Elizabeth de la Cruz-Álvarez, Ángel Zúñiga-Romero, Juan Gerardo Reyes-García, Héctor I. Rocha-González, Claudia Ivonne Araiza-Saldaña
Publikováno v:
Drug Development Research. 79:362-369
Painful peripheral neuropathy can be associated with nerve damage caused by diabetes mellitus. Although pregabalin is the first-line therapy for peripheral neuropathy, it shows substantial discontinuation rates, mainly because of nervous system side
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f21bef08471d1ba48c8cbda52a0eb6d
https://doi.org/10.1002/ddr.21473
https://doi.org/10.1002/ddr.21473